| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-10-02 | ST-400 | transfusion-dependent beta-thalassemia | 1-2 | Bioverativ (USA - MA) Sangamo Biosciences (USA - MA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2017-10-02 | VB-111 (ofranergene obadenovec) | glioblastoma | 3 | VBL Therapeutics (Israel) | Cancer - Oncology |
| 2017-10-02 | PRS-343 | HER2-positive solid tumors | 1 | Pieris (Germany) | Cancer - Oncology |
| 2017-09-30 | bb2121, anti-BCMA CAR T cells | relapsed/refractory multiple myeloma | 1 - OLE | Bluebird bio (USA - MA) | Cancer - Oncology |
| 2017-09-30 | epacadostat and Keytruda® (pembrolizumab) | advanced tumors | 1-2 | Incyte (USA - DE) Merck&Co (USA - NJ) | Cancer - Oncology |
| 2017-09-29 | FYB201 (biosimilar ranibizumab ) biosimilar version of Lucentis® | wet age-related macular degeneration (wet AMD) | 3 | Formycon (Germany) bioeq GmbH (Germany) | Ophtalmological diseases |
| 2017-09-29 | ZX008 (fenfluramine hydrochloride) | Dravet syndrome | 3 | Zogenix (USA - NY) | Rare diseases - Neurological diseases |
| 2017-09-28 | NeuVax™ (nelipepimut-S) | node-positive breast cancer | 3 | Galena Biopharma (USA - OR) | Cancer - Oncology |
| 2017-09-28 | ABX464 | HIV infection | 1-2 | Abivax (France) | Infectious diseases |
| 2017-09-28 | bb21217 | relapsed/refractory multiple myeloma | 1 | Bluebird bio (USA - MA) | Cancer - Oncology |
| 2017-09-28 | Ery-asp®/Graspa® (eryaspase - L-asparaginase loaded erythrocytes) | acute lymphoblastic leukemia (ALL) | 1 | Erytech Pharma (France) | Cancer - Oncology |
| 2017-09-28 | AsiDNA™ and belinostat | preclinical | Onxeo (France) | Cancer - Oncology | |
| 2017-09-28 | pembrolizumab and olaptesed pegol (NOX-A12) | metastatic colorectal cancer, metastatic pancreatic cancer | 1-2 | Noxxon Pharma (Germany) Merck&Co (USA - NJ) | Cancer - Oncology |
| 2017-09-27 | THR-687 | preclinical | Thrombogenics (Belgium) | ||
| 2017-09-27 | Remygen® (gamma-Aminobutyric acid) | Diamyd Medical (Sweden) | |||
| 2017-09-27 | RAD140 | hormone receptor positive breast cancer | 1 | Radius Health (USA - MA) | Cancer - Oncology |
| 2017-09-25 | SYL136001v10 | neovascular diseases of the retina including age related macular degeneration (AMD) | preclinical | Sylentis (Spain) | Ophtalmological diseases |
| 2017-09-25 | ARB-1467 | hepatitis B | 2 | Arbutus Biopharma (Canada) | Infectious diseases |
| 2017-09-25 | QR-010 | cystic fibrosis | 1b | ProQR Therapeutics (The Netherlands) | Rare diseases - Genetic diseases - Lung diseases |
| 2017-09-22 | Keyzilen™ (AM-101) | acute peripheral tinnitus | 3 | Auris Medical (Switzerland) | Otorhinolaryngology |
